Arthur Peter Bertolino, EVP and Chief Medical Officer at Revance Therapeutics, Inc. (RVNC), sold 7,753 shares at $39.11 ($303K) on 2015-11-17, disclosed to the SEC on 2015-11-17.
Open-market sale of $303k RVNC by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.11 | 2,277 | $89K | 29.4% |
| 2 | $39.11 | 5,425 | $212K | 70.0% |
| 3 | $39.55 | 15 | $593 | 0.2% |
| 4 | $39.55 | 36 | $1K | 0.5% |
| Total | $39.11 avg | 7,753 | $303K | 100% |